RECRUITINGOBSERVATIONAL
Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
Prospective Observational Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
About This Trial
The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR/EULAR criteria
- Residence in Austria
- Signed and dated consent of the patient in accordance with ICH-GCP guidelines
Who Should NOT Join This Trial:
- pregnancy
- age below 18 years
- Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.)
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR/EULAR criteria
* Residence in Austria
* Signed and dated consent of the patient in accordance with ICH-GCP guidelines
Exclusion Criteria:
* pregnancy
* age below 18 years
* Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.)
Locations (1)
Medical University Innsbruck
Innsbruck, Austria, Austria